| Analysis | Metabolite Name | Measured Value | Units | Group |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.5495 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.5524 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.5609 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.6245 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.6259 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.6400 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.6428 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.6690 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.6695 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.6719 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.6822 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.6885 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.6957 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7087 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7098 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7111 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7193 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7255 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7257 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7262 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7285 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7368 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7392 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7439 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7580 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7699 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7742 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7757 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7846 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7849 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7912 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7918 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.7940 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.8003 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.8191 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.8217 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.8284 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.8287 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.8309 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.8366 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.8397 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.8405 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.8433 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.8663 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.8670 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.8815 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.8835 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.8957 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.8972 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.9018 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.9047 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.9113 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.9135 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.9224 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.9432 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.9491 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.9560 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.9573 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.9655 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.9687 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.9701 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.9846 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.9850 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.9920 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 0.9980 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.0000 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.0088 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.0095 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.0133 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.0160 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.0248 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.0324 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.0398 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.0605 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.0724 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.0788 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.0842 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.0953 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.0981 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.1178 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.1215 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.1237 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.1488 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.1536 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.1747 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.1793 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.1802 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.1990 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.2378 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.2430 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.2653 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.2836 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.2883 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.3181 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.3267 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.3372 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.3485 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.3787 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.3845 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.4241 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.4302 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.4793 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.5452 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.5738 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.5916 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.6654 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.7026 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.7334 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.7382 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.7902 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.8372 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.8407 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.8448 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.9438 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 1.9831 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 2.0433 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 2.0991 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 2.1040 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 2.1131 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 2.1200 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 2.2406 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 2.3809 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 2.5084 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 2.5821 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 2.9856 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 3.1581 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 3.1750 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 3.2956 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 3.3346 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 3.5185 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | trans-4-hydroxyproline | 4.6507 | Peak area | Obese neuropathy |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|